re: News: Starpharma expands AstraZeneca rela...
Don't worry ... I think we will get there. You have an $81 billion dollar company who has has had a look at our technology for the last 12 months saying they are going to be applying to one of their cancer drugs.
I think that validates it ...
In the next couple of months we should get some preliminary results from the phase I docetaxol trial... That will be a game changer. If they can prove what they have in the lab ie no neutropenia, reduced toxicity and increased efficacy then it is game on big time in my opinion.
SPL Price at posting:
75.0¢ Sentiment: LT Buy Disclosure: Held
